Chemical Evaluation of Liquidambar styraciflua L. Fruits Extracts and Their Potential as Anticancer Drugs
- PMID: 36615553
- PMCID: PMC9822488
- DOI: 10.3390/molecules28010360
Chemical Evaluation of Liquidambar styraciflua L. Fruits Extracts and Their Potential as Anticancer Drugs
Abstract
Liquidambar styraciflua L. is an aromatic species, popularly used in traditional Chinese medicine to treat diarrhea, dysentery, coughs, and skin sores. The present study was designed to investigate the chemical composition and biological potential of extracts obtained from the fruits of this plant. For the chemical evaluation, it was used mainly liquid and gas chromatography, plus NMR, and colorimetric methods. The aqueous extract (EA) originated two other fractions: an aqueous (P-EA) and an ethanolic (S-EA). The three extracts were composed of proteins, phenolic compounds, and carbohydrates in different proportions. The analyses showed that the polysaccharide extract (P-EA) contained pectic polysaccharides, such as acetylated and methyl esterified homogalacturonans together with arabinogalactan, while the fraction S-EA presented phenolic acids and terpenes such as gallic acid, protocathecuic acid, liquidambaric acid, combretastatin, and atractyloside A. EA, P-EA, and S-EA showed antioxidant activity, with IC50 values of 4.64 µg/mL, 16.45 µg/mL, and 3.67 µg/mL, respectively. The cytotoxicity followed the sequence S-EA > EA > P-EA, demonstrating that the toxic compounds were separated from the non-toxic ones by ethanol precipitation. While the fraction S-EA is very toxic to any cell line, the fraction P-EA is a promising candidate for studies against cancer due to its high toxicity to tumoral cells and low toxicity to normal cells.
Keywords: Liquidambar styraciflua; antioxidant activity; antitumoral activity.
Conflict of interest statement
The authors declare no conflict of interests.
Figures









Similar articles
-
Liquidambar styraciflua L.: A new potential source for therapeutic uses.J Pharm Biomed Anal. 2019 Sep 10;174:422-431. doi: 10.1016/j.jpba.2019.06.003. Epub 2019 Jun 6. J Pharm Biomed Anal. 2019. PMID: 31220700
-
Variations of the chemical composition and bioactivity of essential oils from leaves and stems of Liquidambar styraciflua (Altingiaceae).J Pharm Pharmacol. 2013 Nov;65(11):1653-63. doi: 10.1111/jphp.12142. Epub 2013 Sep 30. J Pharm Pharmacol. 2013. PMID: 24117424
-
In vitro antioxidant and cytotoxic properties of ethanol extract of Alpinia oxyphylla fruits.Pharm Biol. 2013 Nov;51(11):1419-25. doi: 10.3109/13880209.2013.794844. Epub 2013 Jul 10. Pharm Biol. 2013. PMID: 23841520
-
Chemical profile, antioxidant and anti-inflammatory properties of Miconia albicans (Sw.) Triana (Melastomataceae) fruits extract.J Ethnopharmacol. 2021 Jun 12;273:113979. doi: 10.1016/j.jep.2021.113979. Epub 2021 Feb 27. J Ethnopharmacol. 2021. PMID: 33647428
-
Preclinical anticancer studies on the ethyl acetate leaf extracts of Datura stramonium and Datura inoxia.BMC Complement Med Ther. 2020 Jun 17;20(1):188. doi: 10.1186/s12906-020-02975-8. BMC Complement Med Ther. 2020. PMID: 32552791 Free PMC article.
Cited by
-
Chromosome-level genome assembly of American sweetgum (Liquidambar styraciflua, Altingiaceae).Sci Data. 2024 Oct 3;11(1):1078. doi: 10.1038/s41597-024-03924-7. Sci Data. 2024. PMID: 39362890 Free PMC article.
References
-
- Eid H.H., Labib R.M., Hamid N.S.A., Hamed M.A., Ross S.A. Hepatoprotective and antioxidant polyphenols from a standardized methanolic extract of the leaves of Liquidambar styraciflua L. Bull. Fac. Pharm. Cairo Univ. 2015;53:117–127. doi: 10.1016/j.bfopcu.2015.05.002. - DOI
-
- Mancarz G.F.F., Lobo A.C.P., Baril M.B., Franco F.A., Nakashima T. Antimicrobial and Antioxidant Activity of the Leaves, Bark and Stems of Liquidambar styraciflua L. (Altingiaceae) Int. J. Curr. Microbiol. Appl. Sci. 2016;5:306–317. doi: 10.20546/ijcmas.2016.501.029. - DOI
-
- Rashed K.N.Z., Sucupira A.C.C., Ferreira P.M.P., Feitosa C.M. Phytoconstituents and evaluation of acetylcholinesterase inhibition by methanol extract of Liquidambar styraciflua (L.) aerial parts. J. Appl. Pharm. 2014;6:143–152. doi: 10.21065/19204159.6.3.123. - DOI
-
- Liu Z., Yang P., Newman R.A. Sweet Gum Fruit Extract as a Therapeutic Agent. U.S. Patent 6,738,537. 2008 May 21;
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources